LXU · Lsb Industries, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $169.49M | - | $155.43M | $151.30M | $143.43M | - | $109.22M | $140.07M | $138.20M | - |
| Cost of Revenue | $133.69M | - | $129.89M | $128.12M | $129.05M | - | $117.16M | $112.66M | $115.93M | - |
| Gross Profit | $35.79M | - | $25.54M | $23.17M | $14.38M | - | ($7.95M) | $27.41M | $22.28M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $13.82M | - | $10.33M | $9.84M | $10.15M | - | $10.04M | $11.55M | $10.29M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $20.92M | - | - | - | $20.12M | - | - | - | $17.11M | - |
| Operating Income | $23.16M | - | $15.63M | $10.49M | $4.47M | - | ($24.42M) | $14.40M | $11.26M | - |
| Interest Expense | $7.12M | - | $7.36M | $7.89M | $8.06M | - | $8.12M | $8.38M | $9.73M | - |
| Income Tax | ($2.13M) | - | $2.54M | $1.08M | ($283.0K) | - | ($4.48M) | $1.25M | $603.0K | - |
| Net Income | $19.68M | - | $7.12M | $3.01M | ($1.64M) | - | ($25.38M) | $9.55M | $5.62M | - |
| EPS - Basic | $0.27 | - | $0.10 | $0.04 | ($0.02) | - | ($0.35) | $0.13 | $0.08 | - |
| EPS - Diluted | $0.27 | - | $0.10 | $0.04 | ($0.02) | - | ($0.35) | $0.13 | $0.08 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20.64M | $19.51M | $27.95M | $5.61M | $15.03M | $20.23M | $42.28M | $216.26M | $125.99M | $98.50M |
| Accounts Receivable | $52.50M | $57.21M | $46.65M | $51.29M | $51.87M | $38.76M | $44.27M | $41.91M | $53.74M | $40.38M |
| Inventory | $23.24M | $18.31M | $19.80M | $24.45M | $25.49M | $24.90M | $21.39M | $21.27M | $21.96M | $28.13M |
| Accounts Payable | $62.47M | $64.51M | $59.99M | $59.58M | $58.85M | $83.50M | $75.73M | $61.34M | $56.06M | $68.32M |
| Current Assets | $321.30M | $293.29M | $270.62M | $255.21M | $299.33M | $309.71M | $314.24M | $332.00M | $399.24M | $436.74M |
| Total Assets | $1.19B | $1.17B | $1.15B | $1.13B | $1.18B | $1.19B | $1.18B | $1.19B | $1.26B | $1.30B |
| Current Liabilities | $104.56M | $105.51M | $95.30M | $96.51M | $119.47M | $135.63M | $124.35M | $97.31M | $109.64M | $118.53M |
| Long-term Debt | $440.43M | $440.30M | $447.58M | $446.37M | $478.17M | $476.16M | $475.99M | $479.77M | $543.84M | $575.87M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $542.95M | $519.97M | $504.61M | $495.80M | $490.56M | $491.64M | $498.96M | $522.79M | $518.18M | $518.33M |
| Retained Earnings | $251.96M | $232.28M | $216.14M | $209.03M | $206.02M | $207.66M | $216.81M | $242.19M | $232.64M | $227.01M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $51.80M | - | - | - | $6.84M | - | - | - | $24.11M | - |
| Investing Cash Flow | ($45.48M) | - | - | - | ($5.27M) | - | - | - | $47.90M | - |
| Financing Cash Flow | ($5.19M) | - | - | - | ($6.76M) | - | - | - | ($44.52M) | - |
| CapEx | $16.98M | - | - | - | $20.87M | - | - | - | $18.29M | - |
| Free Cash Flow | $34.82M | - | - | - | ($14.03M) | - | - | - | $5.82M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 21.1% | - | 16.4% | 15.3% | 10.0% | - | -7.3% | 19.6% | 16.1% | - |
| Operating margin | 13.7% | - | 10.1% | 6.9% | 3.1% | - | -22.4% | 10.3% | 8.1% | - |
| EBITDA margin | 26.0% | - | - | - | 17.1% | - | - | - | 20.5% | - |
| Net margin | 11.6% | - | 4.6% | 2.0% | -1.1% | - | -23.2% | 6.8% | 4.1% | - |
| Free cash flow margin | 20.5% | - | - | - | -9.8% | - | - | - | 4.2% | - |
| FCF / Net income | 1.77 | - | - | - | 8.56 | - | - | - | 1.04 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 8.2% | - | 6.6% | 6.5% | 7.1% | - | 9.2% | 8.2% | 7.4% | - |
| Effective tax rate | -12.1% | - | 26.3% | 26.5% | - | - | - | 11.6% | 9.7% | - |
| Return on assets | 1.7% | - | 0.6% | 0.3% | -0.1% | - | -2.1% | 0.8% | 0.4% | - |
| Return on equity | 3.6% | - | 1.4% | 0.6% | -0.3% | - | -5.1% | 1.8% | 1.1% | - |
| Return on invested capital | 2.4% | - | 1.2% | 0.8% | 0.4% | - | -2.0% | 1.3% | 1.0% | - |
| Liquidity | ||||||||||
| Current ratio | 3.07 | 2.78 | 2.84 | 2.64 | 2.51 | 2.28 | 2.53 | 3.41 | 3.64 | 3.68 |
| Quick ratio | 2.85 | 2.61 | 2.63 | 2.39 | 2.29 | 2.10 | 2.36 | 3.19 | 3.44 | 3.45 |
| Cash ratio | 0.20 | 0.18 | 0.29 | 0.06 | 0.13 | 0.15 | 0.34 | 2.22 | 1.15 | 0.83 |
| Leverage | ||||||||||
| Debt / Equity | 0.81 | 0.85 | 0.89 | 0.90 | 0.97 | 0.97 | 0.95 | 0.92 | 1.05 | 1.11 |
| Debt / Assets | 0.37 | 0.38 | 0.39 | 0.40 | 0.41 | 0.40 | 0.40 | 0.40 | 0.43 | 0.44 |
| Debt / EBITDA | 9.99 | - | - | - | 19.45 | - | - | - | 19.17 | - |
| Interest coverage | 3.3x | - | 2.1x | 1.3x | 0.6x | - | -3.0x | 1.7x | 1.2x | - |
| Equity multiplier | 2.19 | 2.26 | 2.28 | 2.28 | 2.40 | 2.41 | 2.37 | 2.27 | 2.43 | 2.50 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.14 | - | 0.14 | 0.13 | 0.12 | - | 0.09 | 0.12 | 0.11 | - |
| Inventory turnover | 5.75 | - | 6.56 | 5.24 | 5.06 | - | 5.48 | 5.30 | 5.28 | - |
| Days sales outstanding | 113d | - | 110d | 124d | 132d | - | 148d | 109d | 142d | - |
| Days inventory outstanding | 63d | - | 56d | 70d | 72d | - | 67d | 69d | 69d | - |
| Days payable outstanding | 171d | - | 169d | 170d | 166d | - | 236d | 199d | 177d | - |
| Cash conversion cycle | 6d | - | -3d | 24d | 38d | - | -21d | -21d | 35d | - |
| Valuation | ||||||||||
| P / E | 55.2x | - | 78.8x | 195.0x | - | - | - | 62.9x | 109.7x | - |
| P / B | 2.0x | - | 1.1x | 1.1x | 1.0x | - | 1.2x | 1.1x | 1.2x | - |
| P / S | 6.4x | - | 3.7x | 3.7x | 3.3x | - | 5.3x | 4.2x | 4.6x | - |
| EV / EBITDA | 34.2x | - | - | - | 38.1x | - | - | - | 37.4x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 18.2% | - | 42.3% | 8.0% | 3.8% | - | -4.4% | -15.5% | -23.6% | - |
| Revenue CAGR (3y) | -2.2% | - | -5.5% | -19.0% | -10.3% | - | -5.0% | -0.1% | 12.1% | - |
| Revenue CAGR (5y) | 11.6% | - | 16.0% | 7.6% | 11.5% | - | 7.7% | 2.9% | 8.0% | - |
| Gross profit growth (YoY) | 148.8% | - | - | -15.5% | -35.4% | - | -134.6% | -23.9% | -46.5% | - |
| Operating income growth (YoY) | 418.3% | - | - | -27.1% | -60.3% | - | -157.1% | -47.6% | -63.1% | - |
| Net income growth (YoY) | - | - | - | -68.5% | - | - | -228.5% | -61.9% | -64.6% | - |
| EPS growth (YoY) | - | - | - | -69.2% | - | - | -250.0% | -60.6% | -61.9% | - |
| EPS CAGR (3y) | 8.7% | - | 49.4% | -67.4% | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | -85.7% | - |
| FCF CAGR (5y) | 39.6% | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 10.7% | 5.8% | 1.1% | -5.2% | -5.3% | -5.1% | -6.3% | -3.2% | -2.2% | 0.5% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$615.21M totalChemical$615.21M · 100.0%
Product / service
$615.21M totalAmmonium Nitrate And Nitric Acid$241.53M · 39.3%
Urea Ammonium Nitrate UAN$191.06M · 31.1%
Ammonia$146.62M · 23.8%
Other$36.00M · 5.9%
Peer comparison
Same SIC group: Industrial Inorganic Chemicals
Comparing LSB INDUSTRIES against the 5 most active filers in the same SIC group.